1.39
price down icon3.47%   -0.05
after-market 시간 외 거래: 1.42 0.03 +2.16%
loading
전일 마감가:
$1.44
열려 있는:
$1.44
하루 거래량:
330.50K
Relative Volume:
0.54
시가총액:
$2.05M
수익:
$502.40K
순이익/손실:
$-7.91M
주가수익비율:
-0.1394
EPS:
-9.972
순현금흐름:
$-4.32M
1주 성능:
-35.80%
1개월 성능:
-32.85%
6개월 성능:
-67.22%
1년 성능:
-91.45%
1일 변동 폭
Value
$1.36
$1.4499
1주일 범위
Value
$1.36
$2.12
52주 변동 폭
Value
$1.36
$14.58

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
명칭
60 Degrees Pharmaceuticals Inc
Name
전화
202-327-5422
Name
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
직원
3
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
SXTP's Discussions on Twitter

SXTP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
1.39 3.19M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스

pulisher
Jul 21, 2025

60 Degrees Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastFree Popular Stock Recommendations - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a good long term investmentExceptional market performance - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What drives 60 Degrees Pharmaceuticals Inc. Equity Warrant stock priceExtraordinary market timing - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

60 Degrees Pharmaceuticals Inc. Stock Analysis and ForecastOutstanding capital appreciation - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Is 60 Degrees Pharmaceuticals Inc. a good long term investmentFree Investment Community - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

What drives 60 Degrees Pharmaceuticals Inc. stock priceSignificant capital appreciation - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockRapid return acceleration - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about 60 Degrees Pharmaceuticals Inc. stockFree Consultation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Will 60 Degrees Pharmaceuticals Inc. stock benefit from interest rate changesHigh Return Stock Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

60 Degrees Pharmaceuticals Secures $5M in Recent Offering - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

How 60 Degrees Pharmaceuticals Inc. stock reacts to Fed policy changesFree Deep Market Trend Analysis - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

What risks could impact 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performanceWealth Building Stock Portfolio - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals to study tafenoquine against Lyme disease By Investing.com - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals Initiates Study on Tafenoquine's Efficacy Against Lyme Disease and Bartonella Pathogens - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria - The Manila Times

Jul 17, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals to study tafenoquine against Lyme disease - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Major Breakthrough: Anti-Malaria Drug Tafenoquine Being Tested for Lyme Disease Treatment - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals' Warrant Gambit: Balancing Liquidity and Longevity - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals closes $5 million public offering By Investing.com - Investing.com Nigeria

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals closes $5 million public offering - Investing.com Australia

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals Secures $5 Million in Public Offering - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering - Stock Titan

Jul 16, 2025
pulisher
Jul 16, 2025

Form 424B4 60 DEGREES PHARMACEUTICA - StreetInsider

Jul 16, 2025
pulisher
Jul 16, 2025

Trade Desk Shares Surge 15% Amid S&P 500 Inclusion - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

What makes 60 Degrees Pharmaceuticals Inc. Equity Warrant stock price move sharplyFree Stock Market Insider Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Innovative Pharmaceutical: issue of new shares - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

60 Degrees Pharmaceuticals Prices $10 Million Public Offering - citybiz

Jul 15, 2025
pulisher
Jul 15, 2025

Why 60 Degrees Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Return Potential - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performs during market volatilityHigh Return Setup Scanner - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How 60 Degrees Pharmaceuticals Inc. stock performs during market volatilityFree Stock Market Real-Time Monitoring - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

SXTP Crashes 21%—What’s Behind the Unraveling of 60 Degrees Pharma? - AInvest

Jul 15, 2025

60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):